Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

13 terminated/withdrawn out of 1023 trials

Success Rate

94.8%

+8.2% vs industry average

Late-Stage Pipeline

2%

25 trials in Phase 3/4

Results Transparency

1%

2 of 235 completed trials have results

Key Signals

288 recruiting2 with results8 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
338(85.1%)
Phase 2
23(5.8%)
Phase 4
13(3.3%)
Phase 3
12(3.0%)
Phase 1
9(2.3%)
Early Phase 1
2(0.5%)
397Total
N/A(338)
Phase 2(23)
Phase 4(13)
Phase 3(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1023)

Showing 20 of 1023 trials
NCT07851324Not Yet Recruiting

Stromal Desmoplastic Reaction as a Predictive Factor for Lymph Node Metastasis in Medullary Thyroid Cancer

Role: collaborator

NCT07846137Not ApplicableNot Yet Recruiting

The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes

Role: lead

NCT07848061Not Yet Recruiting

A Master Regulator of Lipid-Associated Macrophage Function in Cancer

Role: lead

NCT07848074Phase 4Not Yet Recruiting

Abrocitinib Dose Tapering in Patients With Atopic Dermatitis

Role: lead

NCT07835659Not Yet Recruiting

Retrospective Evaluation of Autonomic Activity Through Electrodermal Activity Measurement During Rehabilitation

Role: lead

NCT06573229Not ApplicableCompleted

LIver FRAilty Management IN Cirrhosis (LIFRAMIN)

Role: lead

NCT07708896Recruiting

Evolution of Chronic Inflammatory Skin Diseases

Role: lead

NCT07837895Recruiting

GCP-R3 Clinical Practice Survey in Research Centers

Role: lead

NCT06590350Completed

Individualized NUTRItional RISK and Oriented Nutritional Support

Role: lead

NCT07812740Recruiting

Italian Trigeminal Autonomic Cephalalgias Assessment Study

Role: collaborator

NCT07834125Not Yet Recruiting

Patients With Cryptogenic Hypertransaminasemia

Role: lead

NCT07494227Not Yet Recruiting

Development of the SC-IBD Self-Care Measurement Scale

Role: lead

NCT06929845Not ApplicableRecruiting

Organoid Models of Hepatocellular Carcinoma

Role: lead

NCT06368895Phase 1Completed

Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment

Role: lead

NCT06944678Recruiting

OHANA: Optimizing Cross-Cultural Care

Role: lead

NCT07828925Completed

Selective Axillary Dissection After Neoadjuvant Chemotherap Yin Patients With Lymphnode-positive Breast Cancer

Role: lead

NCT06879236Recruiting

Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease

Role: lead

NCT07825181Not Yet Recruiting

Homologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in Italy

Role: lead

NCT07826611Not ApplicableNot Yet Recruiting

The Diagnostic Accuracy of the Device Under Development MULTISCOPE

Role: lead

NCT07817524Active Not Recruiting

Clinical Outcome of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients With Severe Left Ventricular Disfunction (CROWN)

Role: lead